Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Falanx Launch Mass Market Security Assessment Tool

4 Oct 2021 07:00

RNS Number : 8274N
Falanx Group Limited
04 October 2021
 

04 October 2021

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Falanx Cyber Launches Mass Market Cyber Security Assessment Tool

Falanx Group Limited (FLX.L), the AIM listed provider of cyber security and strategic intelligence services, is pleased to announce the launch of its new cyber security assessment tool, Falanx: Cyber Exposure Level ("f:CEL").

 

This new service offering is expected to play an important role in Falanx's reconnaissance stage of performing a cyber security risk assessment on businesses in order to assess their overall risk of being attacked or breached. f:CEL uses a multi-point reconnaissance approach to allow an external, non-invasive, light touch approach which requires minimal input from the user. The findings of this new assessment tool are displayed as a Falanx Cyber Exposure Level score. The f:CEL score is comprised of three elements:

 

· Digital Risk - assesses a company's Web and Dark Web content, including its website security

 

· External IP Risk - assesses the security level of a company's public-facing servers

 

· Organisational Risk - assesses how effective a company's operations are in minimising their risk of attack

 

The user submits an easy-to-complete, quick, multiple-choice, online questionnaire following which f:CEL runs its analytical and diagnostic tools before providing its findings and recommendations the next working day. Following the initial sign-up report, f:CEL update checks can be performed regularly so that a business can keep track of their security posture. Each report run provides incremental remedial recommendations for the business to action as well as visibility on how their security posture improves over time.

 

f:CEL is sold on a subscription basis and is consequently expected to generate high quality recurring revenues. Various large channel partners have already expressed their interest in deploying this into their customer bases. Consequently, the Board believes that there is potential for growth, not only from sales of f:CEL itself, but also through incremental follow-on sales of cyber security services such as monitoring and penetration testing.

 

Mike Read, CEO, commented: 

 

"Falanx Cyber has developed a mass-market, technology that will perform an objective and repeatable cyber security risk assessment on businesses. We believe this is an ongoing requirement for companies, of all sizes, in order to maintain a robust resilience against cyber threats"

 

"f:CEL is affordable and easily accessible for all sizes of business and can be deployed via larger partners. Initial deployments have already generated valuable insights to organisations, as well as discussions of sales of other Falanx services. f:CEL will allow executives to plan and budget to address weak areas and, perhaps more significantly, provide Board members with evidence on how they are looking after the business on behalf of all their stakeholders."

 

For more information, please visit https://falanxcyber.com/fcel/

 

 

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMJBLTMTBMBRB
Date   Source Headline
18th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 20214:41 pmRNSSecond Price Monitoring Extn
13th Jan 20214:35 pmRNSPrice Monitoring Extension
13th Jan 20212:05 pmRNSSecond Price Monitoring Extn
13th Jan 20212:00 pmRNSPrice Monitoring Extension
13th Jan 202111:06 amRNSSecond Price Monitoring Extn
13th Jan 202111:00 amRNSPrice Monitoring Extension
13th Jan 20217:00 amRNSTriarii to include Microsoft Azure Sentinel
18th Dec 20207:00 amRNSUpdate on SolarWinds® Orion® Platform Cyberattack
17th Dec 20202:28 pmRNSResult of AGM
17th Dec 20207:00 amRNSInterim results
1st Dec 20207:00 amRNSTotal Voting Rights
23rd Nov 202010:12 amRNSNotice of AGM
4th Nov 20204:42 pmRNSDirector subscriptions/PDMR dealing and TVR
30th Oct 20204:17 pmRNSPublication of final results & total voting rights
30th Oct 20207:00 amRNSPreliminary results for year ended 31 March 2020
28th Oct 20207:00 amRNSFalanx joins SolarWinds TAP
2nd Oct 20201:53 pmRNSHolding(s) in Company
1st Oct 20202:28 pmRNSHolding(s) in Company
1st Oct 20202:21 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSConfirmation of successful fundraising
28th Sep 20204:55 pmRNSProposed Equity Fundraise
18th Sep 20207:00 amRNSStrategic Contract Win
21st Aug 202012:16 pmRNSDirector/PDMR Shareholding
17th Aug 20207:00 amRNSStrategic Contract Win
5th Aug 20207:00 amRNSTrading Statement
24th Jul 20207:00 amRNSHolding(s) in Company
24th Jul 20207:00 amRNSHolding(s) in Company
9th Jul 20202:19 pmRNSHolding(s) in Company
21st Apr 20207:00 amRNSSalary sacrifice, grant of options & PDMR dealing
27th Feb 202011:56 amRNSHolding(s) in Company
2nd Jan 20203:21 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSSale of Furnace and Directorate Change
3rd Dec 20194:40 pmRNSResult of AGM
3rd Dec 20197:00 amRNSInterim Results
22nd Nov 201910:18 amRNSHolding(s) in Company
11th Nov 20197:00 amRNSTrading update, notice of results & notice of AGM
25th Sep 20197:30 amRNSGrant of Share Options
25th Sep 20197:00 amRNSDirector/PDMR Shareholding
24th Sep 201911:37 amRNSDirector/PDMR Shareholding
23rd Sep 20193:13 pmRNSAvailability of report and accounts
19th Sep 20197:00 amRNSAnnual results for the year ended 31 March 2019
31st May 201911:39 amRNSDirector/PDMR Shareholding
29th May 20197:00 amRNSChange of Adviser
28th Mar 20197:00 amRNSDirectorate Change
22nd Mar 20197:00 amRNSChange of Adviser
18th Feb 201910:32 amRNSDirector / PDMR Shareholding
18th Feb 201910:18 amRNSDirector / PDMR Shareholding
21st Dec 20181:01 pmRNSGrant of Share Options
21st Dec 201812:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.